CCDC88B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.381000E-01
Normal-vs-Stage2
4.615000E-01
Normal-vs-Stage3
4.014000E-01
Normal-vs-Stage4
4.093000E-01
Stage1-vs-Stage2
6.102400E-01
Stage1-vs-Stage3
4.917800E-01
Stage1-vs-Stage4
5.780400E-01
Stage2-vs-Stage3
2.860600E-01
Stage2-vs-Stage4
1.213630E-02
Stage3-vs-Stage4
7.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.493200E-01
Normal-vs-AfricanAmerican
4.655200E-01
Normal-vs-Asian
4.956400E-01
Caucasian-vs-AfricanAmerican
7.788600E-01
Caucasian-vs-Asian
2.323200E-01
AfricanAmerican-vs-Asian
5.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.485800E-01
Normal-vs-Female
4.552200E-01
Male-vs-Female
7.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.048000E-01
Normal-vs-Age(41-60Yrs)
4.449800E-01
Normal-vs-Age(61-80Yrs)
4.503000E-01
Normal-vs-Age(81-100Yrs)
4.989800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.757800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.244600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.692800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.575000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.217600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.671000E-01
Normal-vs-Daily Drinker
5.064400E-01
Normal-vs-Weekly Drinker
4.441200E-01
Normal-vs-Occasional Drinker
4.499400E-01
Normal-vs-Social Drinker
4.281800E-01
Non Drinker-vs-Daily Drinker
3.375400E-01
Non Drinker-vs-Weekly Drinker
4.347400E-01
Non Drinker-vs-Occasional Drinker
6.488200E-01
Non Drinker-vs-Social Drinker
2.051600E-01
Daily Drinker-vs-Weekly Drinker
9.498300E-02
Daily Drinker-vs-Occasional Drinker
2.168600E-01
Daily Drinker-vs-Social Drinker
4.230400E-02
Weekly Drinker-vs-Occasional Drinker
8.794000E-01
Weekly Drinker-vs-Social Drinker
5.217800E-01
Occasional Drinker-vs-Social Drinker
5.601400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.618800E-01
Normal-vs-Grade 2
1.172990E-01
Normal-vs-Grade 3
1.677390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.632200E-01
Grade 1-vs-Grade 3
8.420800E-01
Grade 1-vs-Grade 4
5.618800E-01
Grade 2-vs-Grade 3
1.358800E-01
Grade 2-vs-Grade 4
1.172990E-01
Grade 3-vs-Grade 4
1.677390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.766800E-01
Normal-vs-NonDiabetic
4.483000E-01
Diabetic-vs-NonDiabetic
2.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.189000E-01
Normal-vs-NoPancreatitis
4.493200E-01
Pancreatitis-vs-NoPancreatitis
5.591900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.588000E-01
Normal-vs-N1
4.524400E-01
N0-vs-N1
7.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.915600E-01
Normal-vs-TP53-NonMutant
3.797600E-01
TP53-Mutant-vs-TP53-NonMutant
6.039400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
